Complying with Regulatory Guidelines on PGIs - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Complying with Regulatory Guidelines on PGIs

Description:

... present in Drug Substance that are potentially genotoxic Felt to not be adequately covered by ICH Q3 What is Genotoxicity ? – PowerPoint PPT presentation

Number of Views:202
Avg rating:3.0/5.0
Slides: 43
Provided by: TimMa52
Category:

less

Transcript and Presenter's Notes

Title: Complying with Regulatory Guidelines on PGIs


1
Complying with Regulatory Guidelines on PGIs
  • The Role and Challenges for Analytical Chemistry
  • Andrew Baker, Analytical Chemistry,
  • Global Process RD Avlon/Charnwood

2
Content
  • Summary of PGIs
  • Analytical Role
  • Strategies and Examples

3
Introduction
4
Introduction
  • Regulatory Authorities have over the last few
    years become increasingly concerned over the
    presence of impurities present in Drug Substance
    that are potentially genotoxic
  • Felt to not be adequately covered by ICH Q3

5
What is Genotoxicity ?
  • Toxic to DNA
  • Interact directly or indirectly
  • Cause mutations that may lead to cancer

6
Where do they come from ?
  • Most (although not all) arise from the synthetic
    process
  • Typical compounds that may be genotoxic are
    alkylating agents, epoxides, nitrosoamines

7
So why use such substances
  • Produce APIs with desired properties
  • eg Sulphonic Acid (sulphonate esters)
  • Good synthetic reagents
  • High yielding, clean synthetic routes
  • eg Alkyl Halides, Epoxides

8
FDA Structural Alerts
9
Guidelines
  • Little definitive guidance in early days
  • EMEA Guidance effective Jan 2007
  • Introduced concept of Virtually Safe Dose
  • Threshold of Toxicological Concern (TTC)
  • Already well established eg Drinking Water
  • Probability/Risk based
  • Equates to 1.5ug/day (assumes lifetime exposure)

10
Industry View
  • Remains some concern
  • Uncertainty over application
  • Overestimating risk vs other sources eg Food
  • But focus on resolving uncertainty

11
Resolving Uncertainty
  • Key area of uncertainty relates to development
  • Higher limits may be permitted if reduced
    exposure
  • Recognised in EMEA guidelines
  • Industry Task Force developed Staged TTC
  • Relates limits to duration of exposure

12
Role of Analytical Chemistry
13
Analytical Chemistry
  • Managing and Resolving Uncertainty
  • Staged TTC approach
  • Fundamentally relies on knowledge of PGI levels
    present
  • But also
  • Hard Facts and Figures vital for Projects
  • Decision making eg Route Selection

14
Trace Analysis
  • Trace analysis well established arm of analytical
    chemistry
  • But some differences here
  • Diversity of analyte/matrix
  • Significant chemical similarity between analyte
    and matrix
  • Traditional trace techniques limited
    applicability

15
Sound Bites
  • Like looking for needle in a haystack when the
    needle is made of Straw as well.
  • Consider the matrix- Which is easier ?
  • 1ppm Benzene in Toluene
  • 1ppb Benzene in Water

16
Old Examples and Strategy
17
Project A
  • A chloroacetamide
  • GCMS SIM Chromatograms
  • 50ppm (wrt to drug) blue trace
  • Extracted Sample black trace

18
Project A
  • Triple Quad GCMS
  • 0.25 ppm equivalent
  • Presented at BMSS by Mark Jackman AZ PRD

19
Project B
  • Standard
  • Sample

20
Project B
  • Small PGI analyte
  • Matrix well resolved chromatographically
  • Variable ion ratios
  • Key confirmatory criteria
  • Presented at BMSS by Mark Jackman AZPRD

21
Project B
  • Triple Quad GCMS
  • Standard
  • Sample

22
Problems
  • Both required the use of a high(er) end
    analytical technique
  • Both Required significant method development
  • Neither was delivered within timelines required
    by project

23
Challenge at AZ
  • Projects want high quality results
  • Fast
  • How do we do this?
  • Which analytical technique to use?
  • Which detector to use?
  • Which cleanup/sample extraction to use?
  • Provide assurance/have confidence in numbers
  • Also Get method development balance right
  • Simple preferred Complex when required

24
AZ Approach
  • How can we meet this challenge?

25
PGI Analysis Collaboration
  • AstraZeneca Looked for a collaborative partner
  • Expert in chromatography and trace analysis
  • Have an established interest in this area
  • Have a set up that could deliver results fast
  • A partner was found and work started Jan 2007

26
PGI Analysis Collaboration
  • Aim
  • Identify best fit analytical method(s) for
    analysis of any of the FDA structural alert
    classes of compounds
  • Hit suitable technique/approach first time
  • To develop a decision making process
  • Along with framework of analytical methods

27
Collaboration Scope
  • Divided into compound classes
  • Chemical functionality key to solution
  • Range of test analytes
  • Range of test matrices (Generic APIs)
  • Selected to give good representation of chemical
    and physical properties

28
Epoxide Test Analytes
29
Targets for method development
  • Develop method(s)
  • 1ppm analyte in matrix
  • Techniques open but available
  • Extraction vital
  • Mass Spec Sensitivity and Selectivity
  • Fully integrated verification of quantification

30
Currently Available Methods
  • Highest priorities
  • Sulphonate Esters (deriv SHS-GCMS)
  • Alkyl Halides (SHS and SPME GCMS)
  • Haloalkenes (SHS and SPME GCMS)
  • Mustards (deriv SPME-GCMS)
  • Aminoaryls (LCMS switching)
  • Michael Acceptors, Epoxides and Aldehydes coming
    soon

31
Working on
  • Michael Acceptors
  • Epoxides
  • Aldehydes
  • Aziridines
  • Nitros
  • Hydrazine/Azos
  • Problem Compounds

32
Examples of New Approach
33
Project C
  • Chloroether and Small Aliphatic Chloroalcohol
    type substances
  • Ca 12 weeks
  • Investigating and developing method
  • Ca 10 weeks trying things that didnt work
  • Project waiting for information
  • Potential Delays

34
From Collaboration
  • Alkyl Halide test analytes included
  • Chloroethanol
  • Bromoethanol
  • Iodoethanol
  • 2-(2-Chloroethoxy)ethanol
  • 4-chloro-butyl ether
  • A lot of the things tried for Project C were
    unlikely to work

35
Solutions from Collaboration
  • Double Aqueous/Organic Extraction
  • Some Triple Quad GCMS for development
  • GCMS SIM analysis
  • Took about 2-3 weeks
  • A potential saving of 10 weeks

36
Project D
  • Fluorophenethyl Bromide
  • 10 ppm levels in API

37
Compound already studied
  • Fluorobenzyl Bromide
  • Recovery and Linearity data

38
Alkyl Halides by SHS
  • Data from collaboration
  • ppm wrt to 50mg API
  • 33 varied compounds in total on list

39
Alkyl Halides by SPME
  • Data from collaboration

40
Project E
  • Sulphonate Ester
  • Halide
  • 12 Batches
  • 3.5 - 4 Days

41
Confirmation
  • Need to confirm for our API/matrix combination
  • But work is more defined
  • Project can therefore plan
  • Delivering significant time savings

42
Summary
  • PGI analysis is a challenge
  • Requires use of generic methodologies
  • AZ have established a collaboration
  • Will provide such methods for all PGI classes
  • Subjectively is working very well (collating hard
    data)
Write a Comment
User Comments (0)
About PowerShow.com